Aptevo Therapeutics Inc (NASDAQ: APVO)’s stock price has decreased by -7.28 compared to its previous closing price of 0.74. However, the company has seen a -4.20% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-24 that Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Groupon (GRPN), Aptevo Therapeutics (APVO), NewJersey Resources (NJR), American Water Works (AWK) and Frontdoor (FTDR).
Is It Worth Investing in Aptevo Therapeutics Inc (NASDAQ: APVO) Right Now?
The stock has a 36-month beta value of 5.10. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for APVO is 1.60M, and at present, short sellers hold a 2.14% of that float. On April 25, 2024, the average trading volume of APVO was 263.32K shares.
APVO’s Market Performance
APVO stock saw a decrease of -4.20% in the past week, with a monthly decline of -82.98% and a quarterly a decrease of -89.93%. The volatility ratio for the week is 8.81%, and the volatility levels for the last 30 days are 15.42% for Aptevo Therapeutics Inc (APVO). The simple moving average for the past 20 days is -71.71% for APVO’s stock, with a -95.08% simple moving average for the past 200 days.
Analysts’ Opinion of APVO
Piper Jaffray, on the other hand, stated in their research note that they expect to see APVO reach a price target of $6. The rating they have provided for APVO stocks is “Overweight” according to the report published on October 05th, 2017.
APVO Trading at -84.72% from the 50-Day Moving Average
After a stumble in the market that brought APVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.26% of loss for the given period.
Volatility was left at 15.42%, however, over the last 30 days, the volatility rate increased by 8.81%, as shares sank -82.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -89.93% lower at present.
During the last 5 trading sessions, APVO fell by -4.20%, which changed the moving average for the period of 200-days by -99.11% in comparison to the 20-day moving average, which settled at $2.2461. In addition, Aptevo Therapeutics Inc saw -91.43% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APVO
The total capital return value is set at -1.64. Equity return is now at value -123.54, with -63.16 for asset returns.
Based on Aptevo Therapeutics Inc (APVO), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -2.17. The debt to equity ratio resting at 0.44. The interest coverage ratio of the stock is 3.01.
Currently, EBITDA for the company is -28.31 million with net debt to EBITDA at 0.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.64.
Conclusion
To sum up, Aptevo Therapeutics Inc (APVO) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
